Neuronetics, Inc. and Greenbrook TMS Inc. announced an expanded commercial partnership through year end 2028. Under the partnership agreement, Neuronetics will be the exclusive supplier of TMS equipment to Greenbrook. Over time, Neuronetics' NeuroStar devices will replace competitive TMS devices at Greenbrook locations.

The companies will work jointly to grow through co-branding and co-marketing programs, enhanced patient and clinician awareness, improved patient access to care, and collaboration on product development and publications. This expanded partnership will deliver several important synergies, including increased patient awareness and access to care, which it believe will ultimately allow to materially advance the proliferation of TMS as a non-drug alternative for the treatment of mental disorders, including depression, anxiety, and obsessive-compulsive disorder.